STOCK TITAN
  1. Home
  2. Sec-filings
  3. MEDP
  4. [Form 3] Medpace Holdings, Inc. Initial Statement of Beneficial Ownership

Medpace (MEDP) Exec VP Brad Hansman reports stock, option and RSU holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Medpace Holdings, Inc. executive Brad W. Hansman, Exec. VP, Operations, filed an initial ownership report showing his equity position in the company. He directly holds 697 shares of common stock, reflecting his current direct stake.

He also holds an employee stock option for 10,000 shares of Medpace common stock at an exercise price of $410.54 per share, expiring on April 24, 2033, which vests in full on April 24, 2031, subject to continued employment. In addition, he has restricted stock units covering 5,000 shares that vest in full on August 5, 2029 and 500 shares that vest in full on April 24, 2031, each unit representing a contingent right to receive one share of MEDP common stock.

Positive

  • None.

Negative

  • None.
Insider Hansman Brad W.
Role Exec. VP, Operations
Type Security Shares Price Value
holding Restricted Stock Unit -- -- --
holding Restricted Stock Unit -- -- --
holding Employee Stock Option (Right to Buy) -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Unit — 500 shares (Direct, null); Employee Stock Option (Right to Buy) — 10,000 shares (Direct, null); Common Stock — 697 shares (Direct, null)
Footnotes (1)
  1. The restricted stock units vest in full on August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. The restricted stock units vest in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. The option vests in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Direct common stock holding 697 shares Common stock directly owned following Form 3
Employee stock option size 10,000 shares Underlying Medpace common shares for option
Option exercise price $410.54 per share Employee stock option exercise price
Option expiration date April 24, 2033 Employee stock option expiration
RSUs vesting 2029 5,000 units Restricted stock units vesting August 5, 2029
RSUs vesting 2031 500 units Restricted stock units vesting April 24, 2031
Restricted Stock Unit financial
"The restricted stock units vest in full on August 5, 2029, subject to the Reporting Person's continued employment"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Option (Right to Buy) financial
"Employee Stock Option (Right to Buy) ... underlying security title Common Stock, underlying security shares 10000.0000"
contingent right to receive one share financial
"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."
vest in full financial
"The restricted stock units vest in full on April 24, 2031, subject to the Reporting Person's continued employment"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Hansman Brad W.
(Last)(First)(Middle)
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
(Street)
CINCINNATI OHIO 45227
(City)(State)(Zip)
UNITED STATES
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026		3. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Exec. VP, Operations
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock697D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit (1) (1)Common Stock500(2)D
Restricted Stock Unit (3) (3)Common Stock5,000(2)D
Employee Stock Option (Right to Buy) (4)04/24/2033Common Stock10,000$410.54D
Explanation of Responses:
1. The restricted stock units vest in full on August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
2. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
3. The restricted stock units vest in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
4. The option vests in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Stephen P. Ewald, Attorney-in-Fact for Brad W. Hansman06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does Brad W. Hansman report holding in Medpace (MEDP) common stock?

Brad W. Hansman reports directly holding 697 shares of Medpace common stock. This position reflects his current direct equity stake in Medpace Holdings, Inc., as disclosed in his Form 3 initial statement of beneficial ownership.

What stock options does Medpace (MEDP) executive Brad Hansman hold?

Brad Hansman holds an employee stock option for 10,000 shares of Medpace common stock at an exercise price of $410.54 per share, expiring on April 24, 2033, and vesting in full on April 24, 2031, subject to his continued employment.

What restricted stock units does Brad Hansman have in Medpace (MEDP)?

Brad Hansman holds 5,000 restricted stock units vesting in full on August 5, 2029 and 500 restricted stock units vesting in full on April 24, 2031, each representing a contingent right to receive one share of MEDP common stock upon vesting.

When do Brad Hansman’s Medpace (MEDP) restricted stock units vest?

His Medpace restricted stock units vest in two tranches: 5,000 units vest on August 5, 2029, and 500 units vest on April 24, 2031, in each case subject to his continued employment with Medpace or its subsidiaries.

What are the key terms of Brad Hansman’s Medpace (MEDP) stock option?

The key terms are: an option on 10,000 shares of Medpace common stock, an exercise price of $410.54 per share, vesting in full on April 24, 2031, and an expiration date of April 24, 2033, all subject to continued employment.